Intervention Review

Adalimumab for treating rheumatoid arthritis

  1. Federico Navarro-Sarabia1,*,
  2. Rafael Ariza-Ariza2,
  3. Blanca Hernandez-Cruz2,
  4. Isidro Villanueva3

Editorial Group: Cochrane Musculoskeletal Group

Published Online: 20 JUL 2005

Assessed as up-to-date: 19 MAY 2005

DOI: 10.1002/14651858.CD005113.pub2


How to Cite

Navarro-Sarabia F, Ariza-Ariza R, Hernandez-Cruz B, Villanueva I. Adalimumab for treating rheumatoid arthritis. Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD005113. DOI: 10.1002/14651858.CD005113.pub2.

Author Information

  1. 1

    Hospital Universitario Virgen Macarena, Serv. de Reumatología, Sevilla, Spain

  2. 2

    Hospital Universitario Virgen Macarena, Rheumatology, Seville, Spain

  3. 3

    Arizona Arthritis Center, Rheumatology, Tucson, Arizona, USA

*Federico Navarro-Sarabia, Serv. de Reumatología, Hospital Universitario Virgen Macarena, Av. Dr. Fedriani 3, Sevilla, 41009, Spain. federiconavarro@supercable.es.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 20 JUL 2005

SEARCH

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens

or

Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.